Retraction: RNA interference‑mediated USP22 gene silencing promotes human brain glioma apoptosis and induces cell cycle arrest (Oncology Letters (2013) 5 (1290-1294) DOI: 10.3892/ol.2013.1188);RNA interference-mediated USP22 gene silencing promotes human brain glioma apoptosis and induces cell cycle arrest

Oncology Letters

Volumn 5, Issue 4, 2013, Pages 1290-1294

  Li, Zhao Hui ^a   Yu, Yin ^a   Du, Chao ^a   Fu, Hong ^a   Wang, Jian ^b   Tian, Yu ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b INNER MONGOLIA UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

Cell apoptosis; Cell cycle; Human brain glioma; RNA interference; USP22 gene

Indexed keywords

CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GLIOMA; HUMAN; HUMAN CELL; ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA INTERFERENCE; UBIQUITIN SPECIFIC PROTEASE 22 GENE; WESTERN BLOTTING;

EID: 84874446576     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2023.13756     Document Type: Erratum

References (23)

1. Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K and Delattre JY: Primary brain tumours in adults. Lancet 379: 1984-1996, 2012.
2. Hess KR, Broglio KR and Bondy ML: Adult glioma incidence trends in the United States, 1977-2000. Cancer 101: 2293-2299, 2004.
3. Johannesen TB, Langmark F and Lote K: Cause of death and long-term survival in patients with neuro-epithelial brain tumours: a population-based study. Eur J Cancer 39: 2355-2363, 2003.
4. Zhang Y, Chao T, Li R, Liu W, Chen Y, Yan X, Gong Y, Yin B, Liu W, Qiang B, Zhao J, Yuan J and Peng X: MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med (Berl) 87: 43-51, 2009.
5. Komotar RJ, Otten ML, Moise G and Connolly ES Jr: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma-a critical review. Clin Med Oncol 2: 421-422, 2008
6. Stummer W and Kamp MA: The importance of surgical resection in malignant glioma. Curr Opin Neurol 22: 645-649, 2009
7. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E and Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005.
8. Glinsky GV: Death-from-cancer signatures and stem cell contribution to metastatic cancer. Cell Cycle 4: 1171-1175, 2005.
9. Zhang XY, Varthi M, Sykes SM, Phillips C, Warzecha C, Zhu W, Wyce A, Thorne AW, Berger SL and McMahon SB: The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression. Mol Cell 29: 102-111, 2008.
10. Li J, Wang Z and Li Y: USP22 nuclear expression is significantly associated with progression and unfavorable clinical outcome in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 138: 1291-1297, 2012.
11. Yang DD, Cui BB, Sun LY, Zheng HQ, Huang Q, Tong JX and Zhang QF: The co-expression of USP22 and BMI-1 may promote cancer progression and predict therapy failure in gastric carcinoma. Cell Biochem Biophys 61: 703-710, 2011.
12. Liu Y, Yang Y, Xu H and Dong X: Implication of USP22 in the regulation of BMI-1, c-Myc, p16INK4a, p14ARF and cyclin D2 expression in primary colorectal carcinomas. Diagn Mol Pathol 19: 194-200, 2010.
13. Zhang Y, Yao L, Zhang X, Ji H, Wang L, Sun S and Pang D: Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer. J Cancer Res Clin Oncol 137: 1245-1253, 2011.
14. Zhang XY, Pfeiffer HK, Thorne AW and McMahon SB: USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A. Cell Cycle 7: 1522-1524, 2008.
15. Atanassov BS and Dent SY: USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1. EMBO Rep 12: 924-930, 2011.
16. Tang B, Du J, Wang J, Tan G, Gao Z, Wang Z and Wang L: Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis-diammined dichloridoplatium. Oncol Rep 27: 1090-1096, 2012.
17. Glinsky GV, Berezovska O and Glinskii AB: Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 115: 1503-1521, 2005.
18. Liu YL, Yang YM, Xu H and Dong XS: Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer. J Surg Oncol 103: 283-289, 2010.
19. Liu YL, Jiang SX, Yang YM, Xu H, Liu JL and Wang XS: USP22 acts as an oncogene by the activation of BMI-1-mediated INK4a/ARF pathway and Akt pathway. Cell Biochem Biophys 62: 229-235, 2012.
20. Lv L, Xiao XY, Gu ZH, Zeng FQ, Huang LQ and Jiang GS: Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells. Mol Cell Biochem 346: 11-21, 2011.
21. Xu H, Liu YL, Yang YM and Dong XS: Knock-down of ubiq uitin-specific protease 22 by micro-RNA interference inhibits colorectal cancer growth. Int J Colorectal Dis 27: 21-30, 2012.
22. Hu J, Liu YL, Piao SL, Yang DD, Yang YM and Cai L: Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer. Lung Cancer 77: 593-599, 2012.
23. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M and Lazebnik YA: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43, 1995